Toxicities with first-line agents prognostic of improved survival
June 7, 2012
A new retrospective study has analysed whether toxicities associated with sunitinib or sorafenib are associated with improved survival.
Postoperative Complications Affect Long-Term Survival
June 7, 2012
Postoperative complications, including acute renal failure, cardiac and neurological events, postoperative infection and sepsis, are associated with significantly worse long-term survival, according to an analysis of the SEER-Medicare database.
Axitinib May Be Effective as First-Line Therapy for mRCC
June 5, 2012
Axitinib appears to be effective in the first-line treatment of metastatic renal cell carcinoma (mRCC) as evidenced by a long progression-free survival (PFS) and a high objective response rate, according to a new study presented at the American Society of Clinical Oncology 2012 annual meeting.
Â 
